ANI Pharmaceuticals, Inc. (ANIP) financial statements (2020 and earlier)

Company profile

Business Address 210 MAIN STREET WEST
BAUDETTE, MN 56623
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6243312715516911
Cash and cash equivalents6243312715516911
Receivables72655946221713
Inventory, net of allowances, customer advances and progress billings484138261384
Inventory484138261384
Prepaid expense4534121
Other undisclosed current assets1 1 18 
Total current assets:18815313210319320328
Noncurrent Assets
Property, plant and equipment41382011755
Intangible assets, net (including goodwill)184205232178684412
Goodwill4422222
Intangible assets, net (excluding goodwill)180202230176664210
Regulated entity, other noncurrent assets  0    
Restricted cash and investments5555   
Deferred income tax assets38
Other noncurrent assets111    
Other undisclosed noncurrent assets 2822261711 
Total noncurrent assets:269278281220936017
TOTAL ASSETS:45743141232328526445
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2119884103
Accounts payable15943231
Accrued liabilities2221111
Employee-related liabilities442211 
Taxes payable 5 2 4 
Deferred revenue0
Debt1033    
Other undisclosed current liabilities301432824841
Total current liabilities:62166393212134
Noncurrent Liabilities
Long-term debt and lease obligation1766770121113111 
Long-term debt, excluding current maturities1766770121113111 
Liabilities, other than long-term debt70 1   
Accounts payable and accrued liabilities   1   
Other liabilities70     
Other undisclosed noncurrent liabilities  128    
Total noncurrent liabilities:18268198121113111 
Total liabilities:2442332371531251244
Stockholders' equity
Stockholders' equity attributable to parent, including:21319717517016014041
Common stock000000 
Treasury stock, value(1)(1)(0)   (0)
Additional paid in capital20118717917316416090
Accumulated other comprehensive loss(5)(0)     
Retained earnings (accumulated deficit)1811(4)(3)(4)(20)(48)
Other undisclosed stockholders' equity attributable to parent      0
Total stockholders' equity:21319717517016014041
TOTAL LIABILITIES AND EQUITY:45743141232328526445

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues207202177129765630
Cost of revenue(63)(73)(79)(49)(13)(11)(10)
Gross profit:1431299880644420
Operating expenses(76)(59)(42)(37)(24)(24)(25)
Other undisclosed operating income (loss)(51)(34)(28)(22)(7)(1)6
Operating income:1635282033201
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(1)0(0)00(0)
Interest and debt expense(13)(0)(11)(11)(11)(1)(0)
Income from continuing operations before equity method investments, income taxes:33417922190
Other undisclosed income (loss) from continuing operations before income taxes1(14)(1)(0)00 
Income from continuing operations before income taxes:32016922190
Income tax expense (benefit)3(5)(17)(5)(6)9(0)
Income (loss) from continuing operations:615(1)415290
Loss from discontinued operations      (0)
Net income (loss):615(1)415290
Other undisclosed net income attributable to parent      0
Net income (loss) attributable to parent:615(1)415290
Preferred stock dividends and other adjustments      (5)
Other undisclosed net loss available to common stockholders, basic(0)(0) (0)(0)(0)(0)
Net income (loss) available to common stockholders, basic:615(1)41529(5)
Other undisclosed net income available to common stockholders, diluted    00 
Net income (loss) available to common stockholders, diluted:615(1)41529(5)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):615(1)415290
Other comprehensive loss(4)(0)     
Comprehensive income (loss), net of tax, attributable to parent:215(1)415290

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: